BD2F1-Tg(BKV-HIV/tat)#/Cnrm

Status

Available to order

EMMA IDEM:11620
International strain nameBD2F1-Tg(BKV-HIV/tat)#/Cnrm
Alternative nameBKV/ tat transgenic BDF mice
Strain typeTransgenic Strains
Allele/Transgene symbolTg(BKV-HIV/tat)#
Gene/Transgene symbolTg(BKV-HIV-tat)#

Information from provider

ProviderAntonella Caputo
Provider affiliationUniversity of Padova
Genetic informationTo generate transgenic mouse lines carrying BKV/tat-sequences, the linear vector DNA was then microinjected into the pronuclei of fertilized eggs from superovulated BDF1 female mice. BDF1 mice are a hybrid strain obtained by crossing C57BL/6 females with DBA/2 male mice. The hybridization profile is suggestive of a single integration site containing multiple copies of the transgene in a tandem array. The transgene DNA was detected in brain, kidney, thymus, skin, stomach, intestine, lung, liver, and spleen of animals in all mouse lines as tandem insertions in a variable number of copies (5 to 20)/cell.
Phenotypic informationHomozygous:
Transgenic mice carrying a recombinant DNA containing BK virus early region and the human immunodeficiency virus tat gene can develop skin leiomyosarcomas, squamous cell papillomas and carcinomas, adenocarcinomas of skin adnexa, glands, and B-cell lymphomas. The incidence of hepatocellular carcinoma is low but most animals show a liver cell dysplasia of variable degree. Some of these mice are also affected by skin lesions resembling the early stages of Kaposi's sarcoma. This transgenic mouse model is representative of the systemic involvement of tat in human immunodeficiency virus natural infection and may be applied to investigate the role of tat in malignancies associated to AIDS, to study Kaposi's sarcoma pathogenesis, to characterize tumors, hyperplastic and dysplastic lesions, and non-neoplastic lesions established by tat in the skin and liver, and to assess in vivo the efficacy of antiangiogenic and anti-tat-specific drugs. Moreover these mice display a latent epileptic phenotype, indeed they are highly susceptible to the effect of kainate and are predisposed to develop convulsive seizures leading to cell damage. The HIV-1 Tat protein may play an important role in HIV-1 associated neurocognitive disorders (HAND) and the Tg tat mice could represent a useful model to investigate all the comorbidities in the development of HAND.

Heterozygous:
No data with these kind of mice.
Breeding historyOnly backcrossing with BDF1 Charles River
References
  • Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes.;Corallini A, Altavilla G, Pozzi L, Bignozzi F, Negrini M, Rimessi P, Gualandi F, Barbanti-Brodano G, ;1993;Cancer research;53;5569-75; 8221699
  • Promotion of tumour metastases and induction of angiogenesis by native HIV-1 Tat protein from BK virus/tat transgenic mice.;Corallini A, Campioni D, Rossi C, Albini A, Possati L, Rusnati M, Gazzanelli G, Benelli R, Masiello L, Sparacciari V, Presta M, Mannello F, Fontanini G, Barbanti-Brodano G, ;1996;AIDS (London, England);10;701-10; 8805860
  • Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice.;Altavilla G, Trabanelli C, Merlin M, Caputo A, Lanfredi M, Barbanti-Brodano G, Corallini A, ;1999;The American journal of pathology;154;1231-44; 10233861
  • Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane.;Altavilla G, Caputo A, Trabanelli C, Brocca Cofano E, Sabbioni S, Menegatti M A, Barbanti-Brodano G, Corallini A, ;2004;European journal of cancer (Oxford, England : 1990);40;275-83; 14728943
  • Increased excitability in tat-transgenic mice: role of tat in HIV-related neurological disorders.;Zucchini Silvia, Pittaluga Anna, Brocca-Cofano Egidio, Summa Maria, Fabris Marina, De Michele Rita, Bonaccorsi Angela, Busatto Graziella, Barbanti-Brodano Giuseppe, Altavilla Giuseppe, Verlengia Gianluca, Cifelli Pierangelo, Corallini Alfredo, Caputo Antonella, Simonato Michele, ;2013;Neurobiology of disease;55;110-9; 23454193
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requirednot known
Immunocompromisedno

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Literature references

  • Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes.;Corallini A, Altavilla G, Pozzi L, Bignozzi F, Negrini M, Rimessi P, Gualandi F, Barbanti-Brodano G, ;1993;Cancer research;53;5569-75; 8221699
  • Promotion of tumour metastases and induction of angiogenesis by native HIV-1 Tat protein from BK virus/tat transgenic mice.;Corallini A, Campioni D, Rossi C, Albini A, Possati L, Rusnati M, Gazzanelli G, Benelli R, Masiello L, Sparacciari V, Presta M, Mannello F, Fontanini G, Barbanti-Brodano G, ;1996;AIDS (London, England);10;701-10; 8805860
  • Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice.;Altavilla G, Trabanelli C, Merlin M, Caputo A, Lanfredi M, Barbanti-Brodano G, Corallini A, ;1999;The American journal of pathology;154;1231-44; 10233861
  • Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane.;Altavilla G, Caputo A, Trabanelli C, Brocca Cofano E, Sabbioni S, Menegatti M A, Barbanti-Brodano G, Corallini A, ;2004;European journal of cancer (Oxford, England : 1990);40;275-83; 14728943
  • Increased excitability in tat-transgenic mice: role of tat in HIV-related neurological disorders.;Zucchini Silvia, Pittaluga Anna, Brocca-Cofano Egidio, Summa Maria, Fabris Marina, De Michele Rita, Bonaccorsi Angela, Busatto Graziella, Barbanti-Brodano Giuseppe, Altavilla Giuseppe, Verlengia Gianluca, Cifelli Pierangelo, Corallini Alfredo, Caputo Antonella, Simonato Michele, ;2013;Neurobiology of disease;55;110-9; 23454193

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).